Health Condition 1: J454- Moderate persistent asthma
Conditions
Interventions
None listed
Sponsors
Department of Dravyaguna Faculty of Ayurveda
Eligibility
Inclusion criteria
Inclusion criteria: Patient with stable bronchial asthma asper WHO GINA Guidelines for atleast 6 weeks prior to study entry positive test of reversibility FEV1 more than 50 and less than 80 FEV1 and FEV ratio less than 70
Exclusion criteria
Exclusion criteria: Patients with PEFR less than 50 or FEV lessthan 50 patient having pulmonary diseases other than asthma like COPD,fibrotic lung disease,lung TB etc. Pregnant and lactating women Patient with poorly controlled diabetes Patient with poorly controlled HTN(systolic greater than 160 and diastolic greater than 100 Patients on prolonged medications (greater than 6 weeks) that may have influence on the outcome of the study Smoker or alcoholic or drug abuser Patients who have past history of Atrial fibrillation,acute coronary syndrome,MI,stroke or severe arrythmia in last 6 months Patient having systemic illness necessiating long term drug treatment like TB,carcinoma,endocrine disorders etc. Patients who have completed participation in any otherclinical trial during past 6 months. Patient having SPO2 less than 90 Emergency patients requiring O2 nebulization
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure include improvement in asthma symptoms and pulmonary function measured by Grading Analog Scale (GAS), Asthma control test(ACT) and PFTsTimepoint: 90 days study with follow up every 1 month | — |
Secondary
| Measure | Time frame |
|---|---|
| Health-related QOL will be our secondary outcome measure.Timepoint: 90 days study with follow up every 1 month | — |
Countries
India
Contacts
Public ContactDr Poonam Sharma
Banaras Hindu university
Outcome results
None listed